Colon Targeted Rifaximin Nanosuspension for the Treatment of Inflammatory Bowel Disease (IBD).

BACKGROUND Although, a number of formulations have been developed for the treatment of IBD yet the developed formulations are having side effects such as high dose, lack of solubility and permeability problems at the site of action. Very few formulations have been developed for the IBD treatment in the form of nanoparticles. Nanoparticles have shown their… CONTINUE READING